BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 21466828)

  • 1. Biomonitoring equivalents for di-isononyl phthalate (DINP).
    Hays SM; Aylward LL; Kirman CR; Krishnan K; Nong A
    Regul Toxicol Pharmacol; 2011 Jul; 60(2):181-8. PubMed ID: 21466828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Derivation of Biomonitoring Equivalents for di-n-butyl phthalate (DBP), benzylbutyl phthalate (BzBP), and diethyl phthalate (DEP).
    Aylward LL; Hays SM; Gagné M; Krishnan K
    Regul Toxicol Pharmacol; 2009 Dec; 55(3):259-67. PubMed ID: 19751787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Derivation of Biomonitoring Equivalents for di(2-ethylhexyl)phthalate (CAS No. 117-81-7).
    Aylward LL; Hays SM; Gagné M; Krishnan K
    Regul Toxicol Pharmacol; 2009 Dec; 55(3):249-58. PubMed ID: 19751789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomonitoring Equivalents for benzene.
    Hays SM; Pyatt DW; Kirman CR; Aylward LL
    Regul Toxicol Pharmacol; 2012 Feb; 62(1):62-73. PubMed ID: 22178585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomonitoring equivalents for DDT/DDE.
    Kirman CR; Aylward LL; Hays SM; Krishnan K; Nong A
    Regul Toxicol Pharmacol; 2011 Jul; 60(2):172-80. PubMed ID: 21466830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomonitoring Equivalents for bisphenol A (BPA).
    Krishnan K; Gagné M; Nong A; Aylward LL; Hays SM
    Regul Toxicol Pharmacol; 2010 Oct; 58(1):18-24. PubMed ID: 20541576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Derivation of Biomonitoring Equivalents for cyfluthrin.
    Hays SM; Aylward LL; Gagné M; Krishnan K
    Regul Toxicol Pharmacol; 2009 Dec; 55(3):268-75. PubMed ID: 19751788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biomonitoring Equivalents for triclosan.
    Krishnan K; Gagné M; Nong A; Aylward LL; Hays SM
    Regul Toxicol Pharmacol; 2010 Oct; 58(1):10-7. PubMed ID: 20541577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomonitoring Equivalents (BE) dossier for cadmium (Cd) (CAS No. 7440-43-9).
    Hays SM; Nordberg M; Yager JW; Aylward LL
    Regul Toxicol Pharmacol; 2008 Aug; 51(3 Suppl):S49-56. PubMed ID: 18579269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomonitoring Equivalents (BE) dossier for toluene (CAS No. 108-88-3).
    Aylward LL; Barton HA; Hays SM
    Regul Toxicol Pharmacol; 2008 Aug; 51(3 Suppl):S27-36. PubMed ID: 18583006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biomonitoring equivalents for inorganic arsenic.
    Hays SM; Aylward LL; Gagné M; Nong A; Krishnan K
    Regul Toxicol Pharmacol; 2010 Oct; 58(1):1-9. PubMed ID: 20547195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomonitoring equivalents for deltamethrin.
    Aylward LL; Krishnan K; Kirman CR; Nong A; Hays SM
    Regul Toxicol Pharmacol; 2011 Jul; 60(2):189-99. PubMed ID: 21466827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biomonitoring Equivalents (BE) dossier for 2,4-dichlorophenoxyacetic acid (2,4-D) (CAS No. 94-75-7).
    Aylward LL; Hays SM
    Regul Toxicol Pharmacol; 2008 Aug; 51(3 Suppl):S37-48. PubMed ID: 18579270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomonitoring equivalents for hexachlorobenzene.
    Aylward LL; Hays SM; Gagné M; Nong A; Krishnan K
    Regul Toxicol Pharmacol; 2010 Oct; 58(1):25-32. PubMed ID: 20547196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Internal phthalate exposure over the last two decades--a retrospective human biomonitoring study.
    Wittassek M; Wiesmüller GA; Koch HM; Eckard R; Dobler L; Müller J; Angerer J; Schlüter C
    Int J Hyg Environ Health; 2007 May; 210(3-4):319-33. PubMed ID: 17400024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interpreting human biomonitoring data in a public health risk context using Biomonitoring Equivalents.
    Hays SM; Aylward LL
    Int J Hyg Environ Health; 2012 Feb; 215(2):145-8. PubMed ID: 22192580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomonitoring equivalents for 2,2',4,4',5-pentabromodiphenylether (PBDE-99).
    Krishnan K; Adamou T; Aylward LL; Hays SM; Kirman CR; Nong A
    Regul Toxicol Pharmacol; 2011 Jul; 60(2):165-71. PubMed ID: 21466829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comprehensive review of intake estimates of di-isononyl phthalate (DINP) based on indirect exposure models and urinary biomonitoring data.
    Kransler KM; Bachman AN; McKee RH
    Regul Toxicol Pharmacol; 2012 Mar; 62(2):248-56. PubMed ID: 22251514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Occurrence and daily variation of phthalate metabolites in the urine of an adult population.
    Fromme H; Bolte G; Koch HM; Angerer J; Boehmer S; Drexler H; Mayer R; Liebl B
    Int J Hyg Environ Health; 2007 Jan; 210(1):21-33. PubMed ID: 17182278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exposure to phthalates in 5-6 years old primary school starters in Germany--a human biomonitoring study and a cumulative risk assessment.
    Koch HM; Wittassek M; Brüning T; Angerer J; Heudorf U
    Int J Hyg Environ Health; 2011 Jun; 214(3):188-95. PubMed ID: 21371937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.